84 related articles for article (PubMed ID: 1019838)
1. Synergistic lymphocyte stimulation to tumor--specific antigens after immunization with modified tumor cells.
Enker WE; Jacobitz JL
Surg Forum; 1976; 27(62):154-7. PubMed ID: 1019838
[No Abstract] [Full Text] [Related]
2. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
Simmons RL; Rios A
Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
[No Abstract] [Full Text] [Related]
3. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
Simmons RL; Rios A
Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
[No Abstract] [Full Text] [Related]
4. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM
Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949
[No Abstract] [Full Text] [Related]
5. The definitive value of active-specific immunotherapy for experimental carcinoma of the colon.
Enker WE; Jacobitz JL
Surgery; 1976 Aug; 80(2):164-70. PubMed ID: 941090
[TBL] [Abstract][Full Text] [Related]
6. Lymph node reactivity to experimental bladder tumor in preimmunized animals as measured by two parameter flow cytometry.
Collste LG; Kostyrka-Claps ML; Darzynkiewicz Z; Devonec M; Traganos F; Whitmore WF; Melamed MR
Invest Urol; 1979 Nov; 17(3):191-4. PubMed ID: 500314
[TBL] [Abstract][Full Text] [Related]
7. [Method of assessing the functional activity of tumor-associated suppressor cells].
Iudin VM; Semenova-Kobzar' RA; Kushko LIa
Eksp Onkol; 1984; 6(6):37-41. PubMed ID: 6241144
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic action of spleen lymphocytes to simian virus 40-induced tumor cells.
Egusa K
Acta Med Okayama; 1973 Aug; 27(3):107-23. PubMed ID: 4357059
[No Abstract] [Full Text] [Related]
9. Kinetics of antigen-sensitive cells in the lymphoid organs of rats during allotransplantation reaction.
Koníková E; Klobusická M
Folia Biol (Praha); 1981; 27(2):115-25. PubMed ID: 7016602
[TBL] [Abstract][Full Text] [Related]
10. [Transplantability and immunogenicity in mice of lymphoma Nk/Ly cells modified by concanavalin A and neuraminidase].
Bratus' GG; Darchuk GF
Eksp Onkol; 1989; 11(3):35-8. PubMed ID: 2752940
[TBL] [Abstract][Full Text] [Related]
11. Secondary in vitro lymphocyte-proliferative responses to syngeneic plasma cell tumors.
Boyer PJ; Fahey JL
Cancer Res; 1976 Apr; 36(4):1492-8. PubMed ID: 1083290
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of experimental tumors.
Alexander P
Proc R Soc Med; 1971 Oct; 64(10):1042-3. PubMed ID: 5169325
[No Abstract] [Full Text] [Related]
13. Immunotherapy with neuraminidase-treated tumor cells after radiotherapy.
Song CW; Levitt SH
Radiat Res; 1975 Dec; 64(3):485-91. PubMed ID: 1197655
[No Abstract] [Full Text] [Related]
14. Inhibition of mouse tumor cells in vitro by contact with lymph node and tumor cells containing foreign H-2 antigens.
Hellström KE; Hellström I
Fed Proc; 1968; 27(1):39-41. PubMed ID: 4952629
[No Abstract] [Full Text] [Related]
15. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
Lynch DH; Daynes RA; Hodes RJ
J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
[TBL] [Abstract][Full Text] [Related]
16. Regional lymphadenectomy and varied tumor antigenicity.
Ziegler MM; Prehn RT
Surg Forum; 1975; 26():170-2. PubMed ID: 1216102
[No Abstract] [Full Text] [Related]
17. Inhibition and promotion of growth of B77-virus-induced rat tumor with KCl-solubilized tumor cell components.
Simkovic D; Chorváth B; Duraj J; Hlubinová K
Neoplasma; 1978; 25(6):647-51. PubMed ID: 221846
[TBL] [Abstract][Full Text] [Related]
18. The binding affinity of polyoma-tumor specific antigen (TSTA) to receptors of lymphocyte populations.
Ochałek T; Porwit-Bóbr Z; Radzioch D
Folia Histochem Cytochem (Krakow); 1981; 19(4):189-96. PubMed ID: 6174401
[TBL] [Abstract][Full Text] [Related]
19. [The morphofunctional characteristics of lymphoma NK/LY cells treated with concanavalin A and Vibrio cholerae neuraminidase].
Bratus' GG; Naumenko OI; Nastenko EP; Novichenko NL
Tsitologiia; 1990; 32(1):67-73. PubMed ID: 2375060
[TBL] [Abstract][Full Text] [Related]
20. Protection of mice against syngeneic C1300 neuroblastoma challenge by immunization with membranes of C1300 neuroblastoma cells.
Lauro G; Businaro R; Butler RH; Revoltella R
J Natl Cancer Inst; 1980 May; 64(5):1169-72. PubMed ID: 6929017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
